Bortezomib administration examination for high sensitization renal transplantation candidates.

Trial Profile

Bortezomib administration examination for high sensitization renal transplantation candidates.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2015

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jul 2015 Last checked against University Hospital Medical Information Network - Japan record.
    • 13 Jul 2015 Planned number of patients changed from 2 to 5 as reported by University Hospital Medical Information Network - Japan.
    • 07 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top